Cationic liposomal vectors incorporating a bolaamphiphile for oligonucleotide antimicrobials

Biochimica et Biophysica Acta - Biomembranes

Volumn 1859, Issue 10, 2017, Pages 1767-1777

  Mamusa, Marianna ^a   Sitia, Leopoldo ^b,f   Barbero, Francesco ^c,g   Ruyra, Angels ^d   Calvo, Teresa Díaz ^b,e   Montis, Costanza ^a   Gonzalez Paredes, Ana ^c   Wheeler, Grant N ^d   Morris, Christopher J ^d   McArthur, Michael ^b,e   Berti, Debora ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Procarta Biosystems Ltd   (United Kingdom)

^c NANOVECTOR S R L   (Italy)

^d UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^e UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^f ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^g CATALAN INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY ICN2   (Spain)

Author keywords

Antimicrobial resistance; Cationic liposomes; Oligonucleotide therapeutics; Small angle x ray scattering; Transfection

Indexed keywords

1,1' (DODECANE 1,12 DIYL)BIS (9 AMINO 1,2,3,4 TETRAHYDROACRIDINIUM); 1,2 DIOLEOYL SN GLYCERO 3 PHOSPHOETHANOLAMINE; 2 OLEOYL 1 PALMITOYLPHOSPHATIDYLCHOLINE; ANTIINFECTIVE AGENT; CATIONIC LIPOSOMAL VECTOR; CATIONIC SURFACTANT; GLYCEROPHOSPHOETHANOLAMINE; LIPOSOME; TRANSCRIPTION FACTOR DECOY; UNCLASSIFIED DRUG; BOLAAMPHIPHILE; CATION; DRUG CARRIER; FURAN DERIVATIVE; OLIGONUCLEOTIDE; PYRIDONE DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL CELL WALL; CONFOCAL LASER SCANNING MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG STABILITY; EMBRYO; ESCHERICHIA COLI; FLUORESCENCE SPECTROSCOPY; IC50; NONHUMAN; PHOTON CORRELATION SPECTROSCOPY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SURVIVAL; X RAY CRYSTALLOGRAPHY; XENOPUS LAEVIS; ZETA POTENTIAL; ANIMAL; ANTIBIOTIC RESISTANCE; BACTERIUM; CACO-2 CELL LINE; CELL WALL; CHEMISTRY; DRUG EFFECTS; HUMAN; MEDICINAL CHEMISTRY; METABOLISM; PROCEDURES; SMALL ANGLE SCATTERING; TUMOR CELL LINE; X RAY DIFFRACTION;

ANIMALS; ANTI-INFECTIVE AGENTS; BACTERIA; CACO-2 CELLS; CATIONS; CELL LINE, TUMOR; CELL WALL; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG RESISTANCE, BACTERIAL; FURANS; HUMANS; LIPOSOMES; OLIGONUCLEOTIDES; PYRIDONES; SCATTERING, SMALL ANGLE; X-RAY DIFFRACTION; XENOPUS LAEVIS;

EID: 85021652063     PISSN: 00052736     EISSN: 18792642     Source Type: Journal    
DOI: 10.1016/j.bbamem.2017.06.006     Document Type: Article

References (49)

1. Harms, A., Maisonneuve, E., Gerdes, K., Mechanisms of bacterial persistence during stress and antibiotic exposure. Science, 354, 2016, aaf4268, 10.1126/science.aaf4268.
2. Watkins, R.R., Bonomo, R.A., Overview: global and local impact of antibiotic resistance. Infect. Dis. Clin. N. Am. 30 (2016), 313–322, 10.1016/j.idc.2016.02.001.
3. Alanis, A.J., Resistance to antibiotics: are we in the post-antibiotic era?. Arch. Med. Res. 36 (2005), 697–705, 10.1016/j.arcmed.2005.06.009.
4. World Health Organization, Antimicrobial Resistance: Global Report on Surveillance, Geneva, Switzerland. 2014.
5. Czaplewski, L., Bax, R., Clokie, M., Dawson, M., Fairhead, H., Fischetti, V.A., Foster, S., Gilmore, B.F., Hancock, R.E.W., Harper, D., Henderson, I.R., Hilpert, K., Jones, B.V., Kadioglu, A., Knowles, D., Ólafsdóttir, S., Payne, D., Projan, S., Shaunak, S., Silverman, J., Thomas, C.M., Trust, T.J., Warn, P., Rex, J.H., Alternatives to antibiotics—a pipeline portfolio review. Lancet Infect. Dis. 16 (2016), 239–251, 10.1016/S1473-3099(15)00466-1.
6. Mangoni, M.L., McDermott, A.M., Zasloff, M., Antimicrobial peptides and wound healing: biological and therapeutic considerations. Exp. Dermatol. 25 (2016), 167–173, 10.1111/exd.12929.
7. Braun, K., Pochert, A., Lindén, M., Davoudi, M., Schmidtchen, A., Nordström, R., Malmsten, M., Membrane interactions of mesoporous silica nanoparticles as carriers of antimicrobial peptides. J. Colloid Interface Sci. 475 (2016), 161–170, 10.1016/j.jcis.2016.05.002.
8. Kutateladze, M., Adamia, R., Bacteriophages as potential new therapeutics to replace or supplement antibiotics. Trends Biotechnol. 28 (2010), 591–595, 10.1016/j.tibtech.2010.08.001.
9. Extance, A., Biologics target bad bugs. Nat. Rev. Drug Discov. 9 (2010), 177–178, 10.1038/nrd3129.
10. Lind, T.K., Zielińska, P., Wacklin, H.P., Urbańczyk-Lipkowska, Z., Cárdenas, M., Continuous flow atomic force microscopy imaging reveals fluidity and time-dependent interactions of antimicrobial dendrimer with model lipid membranes. ACS Nano 8 (2014), 396–408, 10.1021/nn404530z.
11. Geller, B.L., Antibacterial antisense. Curr. Opin. Mol. Ther. 7 (2005), 109–113 (PMID:15844617).
12. M. McArthur, Transcription factor decoys for the treatment and prevention of infections caused by bacteria including clostridium difficile. US Patent App. 13/802,103, 2013.
13. McArthur, M., Bibb, M.J., Manipulating and understanding antibiotic production in Streptomyces coelicolor A3(2) with decoy oligonucleotides. Proc. Natl. Acad. Sci. 105 (2008), 1020–1025, 10.1073/pnas.0710724105.
14. Weissig, V., Lasch, J., Erdos, G., Meyer, H.W., Rowe, T.C., Hughes, J., DQAsomes: a novel potential drug and gene delivery system made from Dequalinium™. Pharm. Res. 15 (1998), 334–337, 10.1023/A:1011991307631.
15. Mamusa, M., Resta, C., Barbero, F., Carta, D., Codoni, D., Hatzixanthis, K., McArthur, M., Berti, D., Interaction between a cationic bolaamphiphile and DNA: the route towards nanovectors for oligonucleotide antimicrobials. Colloids Surf. B Biointerfaces 143 (2016), 139–147, 10.1016/j.colsurfb.2016.03.031.
16. Lasch, J., Meye, A., Taubert, H., Koelsch, R., Mansa-ard, J., Weissig, V., Dequalinium TM vesicles form stable complexes with plasmid DNA which are protected from DNase attack. Biol. Chem., 380, 1999, 10.1515/BC.1999.080.
17. Marín-Menéndez, A., Montis, C., Díaz-Calvo, T., Carta, D., Hatzixanthis, K., Morris, C.J., McArthur, M., Berti, D., Antimicrobial nanoplexes meet model bacterial membranes: the key role of Cardiolipin. Sci Rep, 7, 2017, 41242, 10.1038/srep41242.
18. Pattni, B.S., Chupin, V.V., Torchilin, V.P., New developments in liposomal drug delivery. Chem. Rev. 115 (2015), 10938–10966, 10.1021/acs.chemrev.5b00046.
19. Balazs, D.A., Godbey, W., Liposomes for use in gene delivery. J. Drug Deliv. 2011 (2011), 1–12, 10.1155/2011/326497.
20. Drulis-Kawa, Z., Dorotkiewicz-Jach, A., Liposomes as delivery systems for antibiotics. Int. J. Pharm. 387 (2010), 187–198, 10.1016/j.ijpharm.2009.11.033.
21. Fillion, P., Desjardins, A., Sayasith, K., Lagacé, J., Encapsulation of DNA in negatively charged liposomes and inhibition of bacterial gene expression with fluid liposome-encapsulated antisense oligonucleotides. Biochim. Biophys. Acta Biomembr. 1515 (2001), 44–54, 10.1016/S0005-2736(01)00392-3.
22. Lichtenberg, D., Characterization of the solubilization of lipid bilayers by surfactants. Biochim. Biophys. Acta Biomembr. 821 (1985), 470–478, 10.1016/0005-2736(85)90052-5.
23. Luciani, P., Berti, D., Fortini, M., Baglioni, P., Ghelardini, C., Pacini, A., Manetti, D., Gualtieri, F., Bartolini, A., Di Cesare Mannelli, L., Receptor-independent modulation of reconstituted Gαi protein mediated by liposomes. Mol. BioSyst., 5, 2009, 356, 10.1039/b815042g.
24. Kline, S.R., Reduction and analysis of SANS and USANS data using IGOR Pro. J. Appl. Crystallogr. 39 (2006), 895–900, 10.1107/S0021889806035059.
25. Lake, J.A., An iterative method of slit-correcting small angle X-ray data. Acta Crystallogr. 23 (1967), 191–194, 10.1107/S0365110X67002440.
26. Pabst, G., Global properties of biomimetic membranes: perspectives on molecular features. Biophys. Rev. Lett. 01 (2006), 57–84, 10.1142/S1793048006000069.
27. Webster, C.A., Di Silvio, D., Devarajan, A., Bigini, P., Micotti, E., Giudice, C., Salmona, M., Wheeler, G.N., Sherwood, V., Bombelli, F.B., An early developmental vertebrate model for nanomaterial safety: bridging cell-based and mammalian toxicity assessment. Nanomedicine 11 (2016), 643–656, 10.2217/nnm.15.219.
28. Israelachvili, J.N., Intermolecular and Surface Forces. 3. ed., 2011, Elsevier, Acad. Press.
29. Farhood, H., Serbina, N., Huang, L., The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer. Biochim. Biophys. Acta Biomembr. 1235 (1995), 289–295, 10.1016/0005-2736(95)80016-9.
30. Nicolosi, D., Scalia, M., Nicolosi, V.M., Pignatello, R., Encapsulation in fusogenic liposomes broadens the spectrum of action of vancomycin against Gram-negative bacteria. Int. J. Antimicrob. Agents 35 (2010), 553–558, 10.1016/j.ijantimicag.2010.01.015.
31. Koltover, I., An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery. Science 281 (1998), 78–81, 10.1126/science.281.5373.78.
32. Zhang, R., Suter, R.M., Nagle, J.F., Theory of the structure factor of lipid bilayers. Phys. Rev. E 50 (1994), 5047–5060, 10.1103/PhysRevE.50.5047.
33. †. Langmuir 19 (2003), 1716–1722, 10.1021/la026052e.
34. Nagle, J.F., Tristram-Nagle, S., Structure of lipid bilayers. Biochim. Biophys. Acta Rev. Biomembr. 1469 (2000), 159–195, 10.1016/S0304-4157(00)00016-2.
35. Pabst, G., Rappolt, M., Amenitsch, H., Laggner, P., Structural information from multilamellar liposomes at full hydration: full q -range fitting with high quality x-ray data. Phys. Rev. E 62 (2000), 4000–4009, 10.1103/PhysRevE.62.4000.
36. Pabst, G., Koschuch, R., Pozo-Navas, B., Rappolt, M., Lohner, K., Laggner, P., Structural analysis of weakly ordered membrane stacks. J. Appl. Crystallogr. 36 (2003), 1378–1388, 10.1107/S0021889803017527.
37. Sakai, K., Tomizawa, H., Tsuchiya, K., Ishida, N., Sakai, H., Abe, M., Characterizing the structural transition of cationic DPPC liposomes from the approach of TEM, SAXS and AFM measurements. Colloids Surf. B: Biointerfaces 67 (2008), 73–78, 10.1016/j.colsurfb.2008.07.017.
38. Kučerka, N., Nieh, M.-P., Katsaras, J., Small-angle scattering from homogenous and heterogeneous lipid bilayers. Adv. Planar Lipid Bilayers Liposomes, 2010, Elsevier.
39. Renner, L.D., Weibel, D.B., Cardiolipin microdomains localize to negatively curved regions of Escherichia coli membranes. Proc. Natl. Acad. Sci. 108 (2011), 6264–6269, 10.1073/pnas.1015757108.
40. Houtkooper, R.H., Vaz, F.M., Cardiolipin, the heart of mitochondrial metabolism. Cell. Mol. Life Sci. 65 (2008), 2493–2506, 10.1007/s00018-008-8030-5.
41. Weissig, V., Lizano, C., Torchilin, V.P., Selective DNA release from DQAsome/DNA complexes at mitochondria-like membranes. Drug Deliv. 7 (2000), 1–5, 10.1080/107175400266722.
42. Lombardi, L., Stellato, M.I., Oliva, R., Falanga, A., Galdiero, M., Petraccone, L., D'Errico, G., De Santis, A., Galdiero, S., Del Vecchio, P., Antimicrobial peptides at work: interaction of myxinidin and its mutant WMR with lipid bilayers mimicking the P. aeruginosa and E. coli membranes. Sci Rep, 7, 2017, 44425, 10.1038/srep44425.
43. Morein, S., Andersson, A.-S., Rilfors, L., Lindblom, G., Wild-type Escherichia coli cells regulate the membrane lipid composition in a “window” between gel and non-lamellar structures. J. Biol. Chem. 271 (1996), 6801–6809, 10.1074/jbc.271.12.6801.
44. Rappolt, M., Hickel, A., Bringezu, F., Lohner, K., Mechanism of the lamellar/inverse hexagonal phase transition examined by high resolution X-ray diffraction. Biophys. J. 84 (2003), 3111–3122, 10.1016/S0006-3495(03)70036-8.
45. Weiss, M.J., Wong, J.R., Ha, C.S., Bleday, R., Salem, R.R., Steele, G.D. Jr., Chen, L.B., Dequalinium, a topical antimicrobial agent, displays anticarcinoma activity based on selective mitochondrial accumulation. Proc. Natl. Acad. Sci. 84 (1987), 5444–5448.
46. Wang, X.-L., Nguyen, T., Gillespie, D., Jensen, R., Lu, Z.-R., A multifunctional and reversibly polymerizable carrier for efficient siRNA delivery. Biomaterials 29 (2008), 15–22, 10.1016/j.biomaterials.2007.08.048.
47. Reynier, P., Briane, D., Coudert, R., Fadda, G., Bouchemal, N., Bissieres, P., Taillandier, E., Cao, A., Modifications in the head group and in the spacer of cholesterol-based cationic lipids promote transfection in melanoma B16-F10 cells and tumours. J. Drug Target. 12 (2004), 25–38, 10.1080/10611860410001683040.
48. Wheeler, G.N., Liu, K.J., Xenopus : an ideal system for chemical genetics. Genesis 50 (2012), 207–218, 10.1002/dvg.22009.
49. Trevor, A.J., Katzung, B.G., Masters, S.B., Kruidering-Hall, M., Pharmacology Examination & Board Review. 2010, McGraw-Hill Medical, New York.